Incorporation of Subsidiary Company

Date: 11th November, 2026 To, To, Manager - Listing Compliance Head – Listing Operations National Stock Exchange of India Corporate Relationship Limited, Exchange Plaza. C-1, Department, BlockG, BSE Limited Bandra Kurla Complex, Bandra (E), Phiroze Jeejeebhoy Towers, Mumbai - 400 051 Dalal Street, Mumbai 400001 SYMBOL: JSLL SCRIP Code: 544476 Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Incorporation of Subsidiary Company. Dear Sir/Madam, In continuation of our earlier intimation dated November 04, 2026, and pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Company has successfully incorporated a subsidiary company under the name “Ayugenomics Private Limited” on 11th November, 2026 in India, under the provisions of the Companies Act, 2013. The requisite disclosures in this regard, as prescribed under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed herewith as Annexure A. The aforesaid information will also be made available on the website of the Company at www.jeenasikho.com. You are requested to kindly take the above information on record. Thanking you, Yours faithfully, For Jeena Sikho Lifecare Limited Manish Grover Managing Director DIN: 07557886 Place: Zirakpur, Punjab Date: 11.11.2026 ANNEXURE – A Disclosure pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026. S. Particulars Details 1. Name of the entity, details in brief such as Name: Ayugenomics Private Limited. size, turnover, etc. Date of Incorporation: 11th November, 2026 CIN: U72100DC2026PTC476416 Country of Incorporation: India. Authorised Share Capital and Paid Up Share Capital: ₹5,00,000 divided into 50,000 equity shares of ₹10 each. Turnover: Not applicable, as the company is newly incorporated and has not commenced business operations. 2. Whether the acquisition would fall within Ayugenomics Private Limited is a subsidiary of related party transaction(s) and whether the Jeena Sikho Lifecare Limited and, accordingly, promoter/promoter group/group companies constitutes a related party of the Company. have any interest in the entity being acquired? If yes, nature of interest and Mr. Manish Grover Promoter and Managing details thereof and whether the same is done Director of Jeena Sikho Lifecare Limited is the at arm's length. Director of Ayugenomics Private Limited. The shares of the subsidiary company is subscribed at “arm’s length” price i.e. face value. 3. Industry to which the entity being acquired Ayurveda. belongs. 4. Objects and impact of acquisition (including Objects: To carry on the business of research, but not limited to, disclosure of reasons for development, testing, diagnostics and clinical acquisition of target entity, if its business is services that combine genomics and allied outside the main line of business of the listed omics sciences with Ayurveda and other entity). AYUSH systems of medicine. This includes developing genomics-based panels, tests and software, clinical decision-support and artificial intelligence platforms, and clinical databases and registries. It also includes conducting clinical studies and evidence-generation programmes; developing, validating, manufacturing, licensing and commercialising evidence-based herbal nutraceutical and botanical products and treatment protocols; and offering wellness, preventive-health, training and certification programmes. The company will work with hospitals, government and state programmes and national and international institutions, including in Japan and other overseas markets. It will seek patents, regulatory approvals and registrations in India and abroad, including CDSCO and the US FDA, and will own and commercialise the intellectual property created by the company. Impact of acquisition: Ayugenomics Private Limited has become a subsidiary of Jeena Sikho Lifecare Limited. 5. Brief details of any governmental or No specific governmental or regulatory regulatory approvals required for the approvals were identified as presently required acquisition. for the incorporation, as per the earlier Board- approved proposal. Any applicable approvals, registrations or licences required for undertaking the proposed business activities shall be obtained from the relevant authorities, as and when required. 6. Indicative time period for completion of the 11th November, 2026 (Date of Incorporation) acquisition. 7. Consideration – whether cash consideration Cash consideration through banking channels or share swap or any other form and details towards subscription to the initial equity share of the same. capital of the subsidiary. 8. Cost of acquisition and/or the price at which ₹3,00,000, comprising subscription to 30,000 the shares are acquired. equity shares of ₹10 each, as approved by the Board of Directors. 9. Percentage of shareholding/control acquired The Company shall hold 60% of the equity and/or number of shares acquired. share capital of Ayugenomics Private Limited, comprising 30,000 equity shares of ₹10 each. 10. Brief background about the entity acquired Ayugenomics Private Limited is a company in terms of products/line of business incorporated in India under the provisions of acquired, date of incorporation, history of the Companies Act, 2013, with its registered last three years turnover, country in which office in India. The company has been the acquired entity has presence and any incorporated to undertake research, other significant information (in brief). development, diagnostics, clinical services and related activities integrating genomics and allied omics sciences with Ayurveda and other AYUSH systems of medicine. Date of Incorporation: 11th November, 2026 CIN: U72100DC2026PTC476416 History/Turnover: Not applicable, as the company is newly incorporated and has no operating history. Country: India For Jeena Sikho Lifecare Limited Manish Grover Managing Director DIN: 07557886 Place: Zirakpur, Punjab Date: 11.11.2026